urkholderia pseudomallei is the causative agent of melioidosis (1). Diagnosis of this disease in areas of endemicity primarily relies on its recovery in culture from an infected site and its subsequent phenotypic and biochemical identification (1). In areas where this organism is endemic, the identity of an isolate is usually suspected on the basis of its antibiotic susceptibility profile (gentamicin resistant, amoxicillin-clavulanic acid sensitive) and characteristic colony types (2). This presumptive identification is usually confirmed on automated systems, such as the Vitek 2 bioMérieux), which takes up to 18 h, or the API 20 NE or API 20 E (bioMérieux), which take 24 to 48 h (2, 3). Updates to the Vitek 2 database have decreased the misidentification rates and increased the reliability of this approach (4). Misidentification by these systems has been reported (5), and their reliability is regionally dependent (6).
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The RapID NF Plus kit (Thermo Fisher Scientific) contains a biochemical panel of tests that consists of 3 unifunctional and 7 bifunctional wells, for a total of 17 results. The interpretation of these strips requires that the Gram stain and oxidase results be known, and results are available in 4 h.
The RapID NF Plus has been reported to be unreliable for the identification of B. pseudomallei (7) . In August 2013, an update of the ERIC electronic compendium (version 1.0.771, patch 0613) added profiles for the identification of B. pseudomallei by the RapID NF Plus kit. A reduction in the time to identification of this organism has the potential to alter patient management in areas where B. pseudomallei is endemic and in those where it is not. We investigated the reliability of this method by performing RapID NF Plus identification on 190 stored isolates of B. pseudomallei.
Clinical strains were taken from a local collection stored on latex beads in a Ϫ70°C freezer. Most of the isolates came from the Townsville, Queensland, Australia, region. The isolates were previously identified by a combination of phenotypic tests, the Vitek and the API 20 NE, and most of the strains were also confirmed by molecular methods. The clinical cases from which the data were drawn were not related. The strains were thawed and inoculated onto horse blood agar (HBA) plates. These plates were incubated aerobically at 36°C for 18 h before single colonies of the isolates were subcultured onto another HBA plate and incubated for another 24 h. The plates were inspected visually for purity and morphology, and an oxidase reaction was performed. We then performed a RapID NF Plus test on each isolate according to the manufacturer's instructions. Briefly, single or representative colonies were inoculated into the RapID NF Plus inoculation fluid. This fluid was then transferred onto a RapID NF Plus strip and subsequently distributed into the reaction cavities. The strips were incubated at 36°C for 4 h. After incubation, the strips were interpreted per the instructions, including the addition of specific reagents to the specified wells. The interpreted results were entered into the electronic RapID code database (ERIC electronic compendium, version 1.0.771, patch 0613), and a microcode corresponding to a specific identification was assigned.
The RapID NF Plus kit identified our previously characterized isolates as B. pseudomallei as the first or only option in 99.47% of the cases (Table 1) . This compares well to published results from other systems of B. pseudomallei identification (Table 2) (2-4, 6-10). The one failed identification was previously characterized by the API 20 NE and the Vitek and serotyped. The stored isolate was retrieved after completion of the study and confirmed to be B. pseudomallei by Vitek II identification and by real-time PCR (RT-PCR) using a previously characterized method (11) .
The RapID NF Plus with the ERIC electronic compendium (version 1.0.771, patch 0613) provides an alternative method for identifying colonies suspected to be B. pseudomallei. This may decrease the time to diagnosis, allow for a more rapid switch to appropriate therapy, and provide an alternative for identification of this critical pathogen in northern Australia. Further validation studies will need to be performed to confirm this finding on a geographically diverse collection of isolates.
